Lytix Biopharma ASA (OSL:LYTIX)
Norway · Delayed Price · Currency is NOK 9.60
-0.30 (-3.03%)
Jun 4, 2026, 9:34 AM CET
Lytix Biopharma ASA Market Cap
Lytix Biopharma ASA has a market cap or net worth of 761.31 million as of June 3, 2026. Its market cap has increased by 44.84% in one year.
Market Cap
761.31M
Enterprise Value
643.15M
Revenue
n/a
Ranking
n/a
PE Ratio
n/a
Stock Price
9.60
Market Cap Chart
Since June 14, 2021, Lytix Biopharma ASA's market cap has increased from 720.55M to 761.31M, an increase of 5.66%. That is a compound annual growth rate of 1.11%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jun 3, 2026 | 761.31M | 12.88% |
| Dec 30, 2025 | 674.43M | 68.03% |
| Dec 30, 2024 | 401.38M | 106.12% |
| Dec 29, 2023 | 194.73M | -37.37% |
| Dec 30, 2022 | 310.93M | -41.63% |
| Dec 30, 2021 | 532.66M | -26.08% |
| Jun 14, 2021 | 720.55M | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Circio Holding ASA | 2.14B |
| Thor Medical ASA | 1.68B |
| ArcticZymes Technologies ASA | 1.15B |
| Nykode Therapeutics AS | 1.02B |
| Zelluna ASA | 570.05M |
| SoftOx Solutions AS | 283.14M |
| Oncoinvent ASA | 205.56M |
| Arctic Bioscience AS | 88.96M |